News

The variant, first detected in the U.S. in late March, has now been identified in arriving international travelers through ...
The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to ...
On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to ...
The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...
Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.
The mRNA vaccines were developed using novel technology that was approved for the first time for public use during the COVID-19 pandemic.
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
The FDA is moving to restrict COVID vaccination to adults 65 and older and other particularly vulnerable people. Learn what’s ...
FDA now requires Pfizer and Moderna COVID-19 vaccines to carry expanded warning labels about risks of myocarditis and pericarditis ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...